Variant report

Variant	nsv878810
Chromosome Location	chr4:30823157-30987395
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr4:30950197-30950798	HCT-116	colon:	n/a	n/a
2	ATF3	chr4:30841402-30842317	HCT-116	colon:	n/a	n/a
3	ATF3	chr4:30841343-30842298	HCT-116	colon:	n/a	n/a
4	ATF3	chr4:30950114-30950725	HCT-116	colon:	n/a	n/a
5	BACH1	chr4:30848797-30849112	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr4:30922061-30922093	H1-hESC	embryonic stem cell:	n/a	n/a
7	BCL11A	chr4:30838885-30839097	H1-hESC	embryonic stem cell:	n/a	n/a
8	BHLHE40	chr4:30944880-30944945	K562	blood:	n/a	n/a
9	BRCA1	chr4:30947284-30947610	Hela-S3	cervix:	n/a	n/a
10	BRCA1	chr4:30950144-30950759	Hela-S3	cervix:	n/a	n/a
11	CBX3	chr4:30838361-30839270	HCT-116	colon:	n/a	n/a
12	CBX3	chr4:30918190-30918728	HCT-116	colon:	n/a	n/a
13	CBX3	chr4:30862532-30863119	HCT-116	colon:	n/a	n/a
14	CBX3	chr4:30952210-30952996	HCT-116	colon:	n/a	n/a
15	CBX3	chr4:30950094-30950771	HCT-116	colon:	n/a	chr4:30950155-30950166
16	CBX3	chr4:30964361-30965120	HCT-116	colon:	n/a	n/a
17	CBX3	chr4:30894307-30894739	HCT-116	colon:	n/a	n/a
18	CBX3	chr4:30950133-30950843	HCT-116	colon:	n/a	chr4:30950155-30950166
19	CBX3	chr4:30826440-30827343	HCT-116	colon:	n/a	n/a
20	CBX3	chr4:30872098-30872705	HCT-116	colon:	n/a	n/a
21	CBX3	chr4:30952208-30953269	HCT-116	colon:	n/a	n/a
22	CBX3	chr4:30822450-30824248	HCT-116	colon:	n/a	n/a
23	CBX3	chr4:30918234-30918771	HCT-116	colon:	n/a	n/a
24	CBX3	chr4:30947120-30948180	HCT-116	colon:	n/a	chr4:30947943-30947954
25	CBX3	chr4:30954241-30955018	HCT-116	colon:	n/a	n/a
26	CBX3	chr4:30964345-30965033	HCT-116	colon:	n/a	n/a
27	CBX3	chr4:30841234-30842190	HCT-116	colon:	n/a	n/a
28	CEBPB	chr4:30866064-30866544	HepG2	liver:	n/a	chr4:30866215-30866228 chr4:30866215-30866228 chr4:30866217-30866226 chr4:30866217-30866226 chr4:30866215-30866226 chr4:30866217-30866226 chr4:30866217-30866226 chr4:30866217-30866228
29	CEBPB	chr4:30950142-30950762	Hela-S3	cervix:	n/a	n/a
30	CEBPB	chr4:30864002-30864202	HepG2	liver:	n/a	n/a
31	CEBPB	chr4:30952249-30953017	HCT-116	colon:	n/a	n/a
32	CEBPB	chr4:30849618-30849932	HepG2	liver:	n/a	chr4:30849749-30849762 chr4:30849751-30849760 chr4:30849750-30849761
33	CEBPB	chr4:30921101-30921348	HepG2	liver:	n/a	chr4:30921227-30921238
34	CEBPB	chr4:30954246-30955090	HCT-116	colon:	n/a	n/a
35	CEBPB	chr4:30849596-30849930	IMR90	lung:	n/a	chr4:30849749-30849762 chr4:30849751-30849760 chr4:30849750-30849761
36	CEBPB	chr4:30838635-30839320	ECC-1	luminal epithelium:	n/a	chr4:30838881-30838893 chr4:30838879-30838896
37	CEBPB	chr4:30838607-30839210	HCT-116	colon:	n/a	chr4:30838881-30838893 chr4:30838879-30838896
38	CEBPB	chr4:30898832-30899008	HepG2	liver:	n/a	n/a
39	CEBPB	chr4:30905100-30905488	IMR90	lung:	n/a	n/a
40	CEBPB	chr4:30822399-30824249	HCT-116	colon:	n/a	n/a
41	CEBPB	chr4:30952268-30952853	Hela-S3	cervix:	n/a	n/a
42	CEBPB	chr4:30849619-30849886	Hela-S3	cervix:	n/a	chr4:30849749-30849762 chr4:30849751-30849760 chr4:30849750-30849761
43	CEBPB	chr4:30866108-30866267	H1-hESC	embryonic stem cell:	n/a	chr4:30866215-30866228 chr4:30866215-30866228 chr4:30866217-30866226 chr4:30866217-30866226 chr4:30866215-30866226 chr4:30866217-30866226 chr4:30866217-30866226 chr4:30866217-30866228
44	CEBPB	chr4:30947234-30947551	Hela-S3	cervix:	n/a	n/a
45	CEBPB	chr4:30950012-30950922	HCT-116	colon:	n/a	n/a
46	CEBPB	chr4:30862309-30863243	HCT-116	colon:	n/a	n/a
47	CEBPB	chr4:30947001-30947718	HCT-116	colon:	n/a	n/a
48	CEBPB	chr4:30903333-30904643	HCT-116	colon:	n/a	chr4:30904108-30904121
49	CEBPB	chr4:30866114-30866396	A549	lung:	n/a	chr4:30866215-30866228 chr4:30866215-30866228 chr4:30866217-30866226 chr4:30866217-30866226 chr4:30866215-30866226 chr4:30866217-30866226 chr4:30866217-30866226 chr4:30866217-30866228
50	CEBPB	chr4:30877289-30878093	HCT-116	colon:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:30906189-30906239	ECC-1	luminal epithelium:	n/a
2	chr4:30906189-30906239	ovcar-3	ovarian:	n/a
3	chr4:30952584-30952634	GM06990	blood:	n/a
4	chr4:30906189-30906239	HepG2	liver:	n/a
5	chr4:30952584-30952634	Hela-S3	cervix:	n/a
6	chr4:30952584-30952634	AG09319	gingival:	n/a
7	chr4:30906189-30906239	CMK	blood:	n/a
8	chr4:30906189-30906239	MCF-7	breast:	n/a
9	chr4:30952584-30952634	Hepatocyte	liver:	n/a
10	chr4:30855141-30855191	HCT-116	colon:	n/a
11	chr4:30906189-30906239	AG09319	gingival:	n/a
12	chr4:30838902-30838952	HRE	kidney:	n/a
13	chr4:30906189-30906239	PFSK-1	brain:	n/a
14	chr4:30838902-30838952	HCPEpiC	choroid plexus:	n/a
15	chr4:30952584-30952634	SK-N-MC	brain:	n/a
16	chr4:30906189-30906239	HCT-116	colon:	n/a
17	chr4:30855141-30855191	AG10803	skin:	n/a
18	chr4:30952584-30952634	HRCEpiC	kidney:	n/a
19	chr4:30838902-30838952	HL-60	blood:	n/a
20	chr4:30906189-30906239	HCF	heart:	n/a
21	chr4:30906189-30906239	HPAEpiC	pulmonary alveolar:	n/a
22	chr4:30906189-30906239	NHDF-neo	bronchial:	n/a
23	chr4:30906189-30906239	AG09309	skin:	n/a
24	chr4:30952584-30952634	AG09309	skin:	n/a
25	chr4:30952584-30952634	NHBE	bronchial:	n/a
26	chr4:30838902-30838952	AG10803	skin:	n/a
27	chr4:30952584-30952634	ProgFib	skin:	n/a
28	chr4:30838902-30838952	SAEC	small airway:	n/a
29	chr4:30906189-30906239	AG10803	skin:	n/a
30	chr4:30906189-30906239	SKMC	muscle:	n/a
31	chr4:30906189-30906239	K562	blood:	n/a
32	chr4:30952584-30952634	HRE	kidney:	n/a
33	chr4:30838902-30838952	MCF-7	breast:	n/a
34	chr4:30952584-30952634	NH-A	brain:	n/a
35	chr4:30952584-30952634	BE2_C	brain:	n/a
36	chr4:30952584-30952634	CMK	blood:	n/a
37	chr4:30906189-30906239	PANC-1	pancreas:	n/a
38	chr4:30855141-30855191	SK-N-MC	brain:	n/a
39	chr4:30952584-30952634	HCPEpiC	choroid plexus:	n/a
40	chr4:30906189-30906239	HNPCEpiC	eye:	n/a
41	chr4:30855141-30855191	A549	lung:	n/a
42	chr4:30838902-30838952	SK-N-SH_RA	brain:	n/a
43	chr4:30906189-30906239	LNCaP	prostate:	n/a
44	chr4:30906189-30906239	BJ	skin:	n/a
45	chr4:30838902-30838952	NT2-D1	testis:	n/a
46	chr4:30855141-30855191	PFSK-1	brain:	n/a
47	chr4:30906189-30906239	Hepatocyte	liver:	n/a
48	chr4:30855141-30855191	AoSMC	blood vessel:	n/a
49	chr4:30906189-30906239	AG04449	skin:	fetal
50	chr4:30855141-30855191	T-47D	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:30860982..30862636-chr4:30867110..30869327,2	MCF-7	breast:
2	chr4:30852819..30854530-chr4:30859220..30861561,2	MCF-7	breast:
3	chr4:30821360..30824099-chr4:30824392..30825995,2	MCF-7	breast:
4	chr4:30960624..30962143-chr4:30965846..30967698,2	MCF-7	breast:
5	chr4:30860982..30862636-chr4:30867110..30869327,2	MCF-7	breast:
6	chr4:30821360..30824099-chr4:30824392..30825995,2	MCF-7	breast:
7	chr4:30912706..30915517-chr4:30915554..30917993,2	MCF-7	breast:
8	chr4:30912706..30915517-chr4:30915554..30917993,2	MCF-7	breast:
9	chr12:75904962..75905804-chr4:30849414..30850313,2	MCF-7	breast:
10	chr4:30960624..30962143-chr4:30965846..30967698,2	MCF-7	breast:
11	chr4:30717567..30718089-chr4:30862406..30862959,2	MCF-7	breast:
12	chr4:30852819..30854530-chr4:30859220..30861561,2	MCF-7	breast:
13	chr4:30917786..30919425-chr4:30920654..30922695,2	K562	blood:

Variant related genes	Relation type
ENSG00000250624	TF binding region
PCDH7	TF binding region
ENSG00000250624	CpG island
PCDH7	CpG island
ENSG00000169851	chromatin interactions
ENSG00000111615	chromatin interactions

Extended variants
information (count: 6390 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:6390 , 50 per page) page: 1 2 3 4 5 6 7 ... 128

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13145415	chr4:30823157-30823158	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs188710520	chr4:30823208-30823209	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs566091492	chr4:30823209-30823210	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs369240636	chr4:30823225-30823226	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs191815262	chr4:30823255-30823256	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs548591116	chr4:30823260-30823261	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs570194962	chr4:30823266-30823267	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs146368263	chr4:30823275-30823276	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs184056522	chr4:30823286-30823287	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs577333666	chr4:30823313-30823314	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs545952926	chr4:30823314-30823315	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs553584558	chr4:30823330-30823331	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs138454113	chr4:30823334-30823335	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs143110194	chr4:30823396-30823397	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs79475751	chr4:30823424-30823425	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs569945424	chr4:30823512-30823513	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs560533104	chr4:30823573-30823574	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs77343141	chr4:30823593-30823594	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs543479482	chr4:30823594-30823595	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs564951621	chr4:30823601-30823602	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs186636775	chr4:30823617-30823618	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs191437992	chr4:30823627-30823628	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs559721414	chr4:30823631-30823632	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs75997028	chr4:30823636-30823637	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs548638306	chr4:30823670-30823671	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs570034069	chr4:30823680-30823681	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs144229660	chr4:30823701-30823702	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs552594352	chr4:30823733-30823734	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs10553337	chr4:30823743-30823744	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs35651966	chr4:30823749-30823750	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs114359963	chr4:30823761-30823762	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs535261381	chr4:30823789-30823790	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs183917897	chr4:30823791-30823792	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs148726230	chr4:30823837-30823838	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs566326324	chr4:30823880-30823881	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs554157453	chr4:30823886-30823887	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs535031999	chr4:30823922-30823923	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs187110561	chr4:30823931-30823932	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs543152641	chr4:30823962-30823963	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs555181642	chr4:30823987-30823988	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs114811989	chr4:30824010-30824011	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs576865212	chr4:30824033-30824034	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs376950237	chr4:30824034-30824035	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs10517219	chr4:30824065-30824066	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs10012692	chr4:30824080-30824081	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs548476848	chr4:30824148-30824149	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs563676553	chr4:30824150-30824151	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs142322182	chr4:30824152-30824153	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs543535100	chr4:30824196-30824197	Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs556868525	chr4:30824245-30824246	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
Oral squamous cell carcinoma	17134496	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Lung cancer	18438408	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21858162	CNVD
small cell lung cancer	20016488	CNVD
Cancer	21183584	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	22183965	CNVD
Prostate cancer	18632612	CNVD
Olfactory neuroblastoma	18408657	CNVD
Cancer	22183965	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Prostate cancer	16573809	CNVD
Myelofibrosis	22110671	CNVD
Tetralogy of Fallot	22912587	CNVD
Renal cell carcinoma	18194544	CNVD
Colorectal cancer	16774939	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:1093 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:30795800-30824000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr4:30813800-30835800	Weak transcription	Colon Smooth Muscle	Colon
3	chr4:30817600-30824000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
4	chr4:30818600-30823600	Weak transcription	HUES6 Cell Line	embryonic stem cell
5	chr4:30820400-30824600	Weak transcription	Aorta	Aorta
6	chr4:30820800-30823400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
7	chr4:30821200-30823200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
8	chr4:30821600-30823200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
9	chr4:30821600-30823200	Weak transcription	HUES48 Cell Line	embryonic stem cell
10	chr4:30821800-30823400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
11	chr4:30822600-30823800	Enhancers	Hela-S3	cervix
12	chr4:30822600-30823800	Enhancers	HSMM	muscle
13	chr4:30822800-30823200	Enhancers	HMEC	breast
14	chr4:30822800-30824400	Enhancers	Fetal Heart	heart
15	chr4:30823000-30823200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
16	chr4:30823000-30823200	Enhancers	Ovary	ovary
17	chr4:30823000-30823200	Enhancers	Right Ventricle	heart
18	chr4:30823000-30823200	Enhancers	NH-A	brain
19	chr4:30823000-30823400	Enhancers	Fetal Stomach	stomach
20	chr4:30823000-30823600	Enhancers	Stomach Smooth Muscle	stomach
21	chr4:30823000-30824000	Enhancers	Muscle Satellite Cultured Cells	--
22	chr4:30823000-30824200	Enhancers	HUES64 Cell Line	embryonic stem cell
23	chr4:30823000-30824200	Enhancers	HSMMtube	muscle
24	chr4:30823000-30825000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
25	chr4:30823200-30823400	Enhancers	Brain Anterior Caudate	brain
26	chr4:30823200-30823600	Weak transcription	Right Ventricle	heart
27	chr4:30823200-30824000	Flanking Active TSS	NH-A	brain
28	chr4:30823200-30824200	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr4:30823200-30824200	Enhancers	HUES48 Cell Line	embryonic stem cell
30	chr4:30823200-30825200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
31	chr4:30823400-30823800	Enhancers	iPS-18 Cell Line	embryonic stem cell
32	chr4:30823400-30823800	Enhancers	HUVEC	blood vessel
33	chr4:30823400-30824200	Enhancers	iPS-15b Cell Line	embryonic stem cell
34	chr4:30823400-30824200	Enhancers	NHEK	skin
35	chr4:30823600-30823800	Enhancers	Fetal Muscle Leg	muscle
36	chr4:30823600-30824000	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr4:30823600-30824000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
38	chr4:30823600-30824000	Active TSS	Right Ventricle	heart
39	chr4:30823600-30824200	Enhancers	H1 Cell Line	embryonic stem cell
40	chr4:30823600-30824200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr4:30823600-30824200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr4:30823600-30824200	Active TSS	Stomach Smooth Muscle	stomach
43	chr4:30823800-30824200	Flanking Active TSS	Hela-S3	cervix
44	chr4:30823800-30824200	Flanking Active TSS	HSMM	muscle
45	chr4:30823800-30826600	Weak transcription	HUVEC	blood vessel
46	chr4:30823800-30827000	Weak transcription	Fetal Muscle Leg	muscle
47	chr4:30824000-30824200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
48	chr4:30824000-30824200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
49	chr4:30824000-30824200	Enhancers	NH-A	brain
50	chr4:30824000-30824800	Weak transcription	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links